MUC1 and idiopathic pulmonary fibrosis: Arnold et al. [18] compared baseline KL-6 levels in patients with COVID-19 and a cohort of IPF, and found that the KL-6 level showed no significant difference between severe COVID-19 and IPF, while KL-6 levels were significantly lower in mild or moderate COVID-19 when compared with IPF.